Outsourcing is booming across all platforms, from fill/finish to cell therapies, as companies pursue efficiency, scale, and strategic flexibility.
Yasmin Timol
Advertisement
Yasmin Timol is project manager and market researcher at BioPlan Associates.
Articles by Yasmin Timol
Advertisement
Latest Updated Articles
Outsourcing Hits Record Levels for All Bioprocess PlatformsPublished: July 25th 2025 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
From Parm to Pharm: Avantor, p-Chip Bring COI Compliance to Clinical Consumables
2
Ask the Expert: Commenting on Draft Regulations
3
SK pharmteco Invests in California Site to Overcome Peptide Purification Bottlenecks
4
A-TEEM: A Novel, Powerful Tool for Evaluating and Monitoring Cell Culture Media
5
